miR-30b suppresses the progression of breast cancer through inhibition of the PI3K/Akt signaling pathway by targeting Derlin-1.

Zhou, Jun; Xiang, Ai-Zhai; Guo, Ju-Feng; Cui, Hai-Dong

Zhou, Jun; Xiang, Ai-Zhai; Guo, Ju-Feng; Cui, Hai-Dong.

Afiliação

Zhou J; Department of Breast Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Xiang AZ; Department of Breast Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Guo JF; Department of Breast Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Cui HD; Department of Breast Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.

Transl Cancer Res ; 8(1): 180-190, 2019 Feb.

Article em En | MEDLINE | ID: mdl-35116747

Palavras-chave

Derlin-1; PI3K/Akt; breast cancer; miR-30b; progression

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Cancer Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google